Non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from a family donor based on fetomaternal microchimerism in pediatric hematologic malignancies

J Pediatr Hematol Oncol. 2004 Jan;26(1):68-71. doi: 10.1097/00043426-200401000-00020.

Abstract

Based on recent fetomaternal microchimerism/tolerance theory, two children with acute lymphoblastic leukemia underwent non-T-cell-depleted hematopoietic stem cell transplants (SCT) from haploidentical HLA 2 loci-mismatched family donors (one from a sibling, one from the mother). Engraftment was achieved in two patients. In two recipients, acute graft-versus-host disease was limited to grade II or less, and no chronic graft-versus-host disease developed. Both of these patients have maintained complete remission for more than 8 months post-SCT. Non-T-cell-depleted SCT from haploidentical HLA 2 loci-mismatched family donors seems feasible if microchimerism is detectable.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Chimera
  • Disease-Free Survival
  • Female
  • Fetomaternal Transfusion
  • Graft Survival
  • Graft vs Host Disease
  • Haplotypes
  • Hematologic Neoplasms / complications
  • Hematologic Neoplasms / therapy*
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hematopoietic Stem Cell Transplantation / methods*
  • Histocompatibility / immunology*
  • Histocompatibility Testing
  • Humans
  • Immune Tolerance*
  • Male
  • Nuclear Family
  • Pregnancy
  • Tissue Donors*